Molecular angiogenic signaling in angiofibromas after embolization: Implications for therapy

Archives of Otolaryngology - Head and Neck Surgery

Volumn 134, Issue 11, 2008, Pages 1170-1176

  Ngan, Bo Yee ^a   Forte, Vito ^a   Campisi, Paolo ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN RECEPTOR; CD133 ANTIGEN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; KI 67 ANTIGEN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; TIE 1 RECEPTOR; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ANGIOGENESIS; ANTIANGIOGENIC THERAPY; ARTICLE; ARTIFICIAL EMBOLISM; ENDOTHELIUM CELL; HEMANGIOFIBROMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MESENCHYMAL STEM CELL; PATHOGENESIS; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ADOLESCENT; ANGIOFIBROMA; ANGIOGENESIS INDUCING AGENTS; APOPTOSIS; CELL HYPOXIA; CELL PROLIFERATION; CHILD; COMBINED MODALITY THERAPY; DNA REPLICATION; EMBOLIZATION, THERAPEUTIC; ENDOTHELIUM, VASCULAR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MALE; MESENCHYMAL STEM CELLS; NEOPLASM PROTEINS; NEOVASCULARIZATION, PATHOLOGIC; OTORHINOLARYNGOLOGIC NEOPLASMS; SIGNAL TRANSDUCTION; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 56649121937     PISSN: 08864470     EISSN: 08864470     Source Type: Journal    
DOI: 10.1001/archotol.134.11.1170     Document Type: Article

References (22)

1. Choi K, Kennedy M, Kazarov A, Papadimitriou JC, Keller G. A common precursor for hematopoietic and endothelial cells. Development. 1998;125(4):725-732.
2. Gang EJ, Jeong JA, Han S, Yan Q, Jeon CJ, Kim H. In vitro endothelial potential of human UC blood-derived mesenchymal stem cells. Cytotherapy. 2006;8(3):215-227.
3. Olsson A-K, Dimberg A, Kreuger J, Claesson-Welsh L. VEGF receptor signaling: in control of vascular function. Nat Rev Mol Cell Biol. 2006;7(5):359-371.
4. Nagai MA, Butugan O, Lugullo A, Brentani MM. Expression of growth factors, proto-oncogenes and p53 in nasopharyngeal angiofibromas. Laryngoscope. 1996;106(2, pt 1):190-195.
5. Brieger J, Wierzbicka M, Sokolov M, Roth Y, Szyfter W, Mann WJ. Vessel density, proliferation and immunolocalization of vascular endothelial growth factor in juvenile nasopharyngeal angiofibromas. Arch Otolaryngol Head Neck Surg. 2004;130(6):727-731.
6. Saylam G, Yücel OT, Sungur A, Onerci M. Proliferation, angiogenesis and hormonal markers in juvenile nasopharyngeal angiofibroma. Int J Pediatr Otorhinolaryngol. 2006;70(2):227-234.
7. Schuon R, Brieger J, Hemrich UR, Roth Y, Szyfter W, Mann WJ. Immunohistochemical analysis of growth mechanisms in juvenile nasopharyngeal angiofibroma. Eur Arch Otorhinolaryngol. 2007;264(4):389-394.
8. Maharaj ASR, Saint-Geniez M, Maldonado AE, D'Amore PA. Vascular endothelial growth factor localization in the adult. Am J Pathol. 2006;168(2):639-648.
9. Pilch B. Head and Neck Surgical Pathology. Philadelphia, PA: Lippincott Williams & Wilkins; 2001:167-170.
10. Neel HB III, Whicker JH, Devine KD, Weiland LH. Juvenile angiofibroma: review of 120 cases. Am J Surg. 1973;126(4):547-556.
11. Harrison DFN. The natural history, pathogenesis, and treatment of juvenile angiofibroma. Arch Otolaryngol Head Neck Surg. 1987;113(9):936-942.
12. Sternberg SS. Pathology of juvenile nasopharyngeal angiofibroma: a lesion of adolescent males. Cancer. 1954;7(1):15-28.
13. Breier G, Damaert A, Plate KH, Risau W. Angiogenesis in embryos and ischemic diseases. Thromb Haemost. 1997;78(1):678-683.
14. Patan S. Vasculogenesis and angiogenesis. Cancer Treat Res. 2004;117:3-32.
15. Parast CV, Mroczkowski B, Pinko C, Misialek S, Khambatta G, Appelt K. Characterization and kinetic mechanism of catalytic domain of human vascular endothelial growth factor receptor-2 tyrosine kinase (VEGFR2-tk), a key enzyme in angiogenesis. Biochemistry. 1998;37(47):16788-16801.
16. Ortega N, Hutchings H, Plouet J. Signal relays in the VEFG system. Front Biosci. 1999;4:D141-D152.
17. Tsiamis AC, Morris PN, Marron MB, Brindle NP. Vascular endothelial growth factor modulates the TIE-2:TIE-1 receptor complex. Microvasc Res. 2002;63(2):149-158.
18. Iljin K, Petrova TV, Veikkola T, Kumar V, Poutanen M, Alitalo K. A fluorescent Tie1 reporter allows monitoring of vascular development and endothelial cell isolation from transgenic mouse embryo. FASEB J. 2002;16(13):1764-1774.
19. Sato TN, Tozawa Y, Deutsch U, et al. Distinct roles of the receptor tyrosine kinase Tie-1 and Tie-2 in blood vessel formation. Nature. 1995;376(6535):70-74.
20. Tang N, Wang L, Esko J, et al. Loss of HIF-1α in endothelial cells disrupts a hypoxia-driven VEGF autocrine loop necessary for tumorigenesis. Cancer Cell. 2004;6(5):485-495.
21. Semenza GL. HIF-1 and tumor progression: pathophysiology and therapeutics. Trends Mol Med. 2002;8(4)(suppl):S62-S67.
22. Pore N, Gupta AK, Cerniglia GJ, et al. Nelfinavir down-regulates hypoxia-inducible factor 1α and VEGF expression and increases tumor oxygenation: implications for radiotherapy. Cancer Res. 2006;66(18):9252-9259.